Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2354 | 3927 | 34.3 | 65% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
333 | 33297 | HUMAN SERUM ALBUMIN//CARDIOTOXICITY//BOVINE SERUM ALBUMIN |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
3024 | 2007 | ENEDIYNES//ENEDIYNE//BERGMAN CYCLIZATION |
14062 | 730 | ARYNES//ARYNE//BENZYNE |
19835 | 423 | INDAZOLES//2H INDAZOLES//INDAZOLE |
23012 | 305 | CINNOLINE//CINNOLINES//COARCTATE |
28454 | 168 | CHLORALOSE//TRICHLOROETHYLIDENE ACETALS//MM2 PARAMETERS |
31675 | 120 | CENT 21142 NURUMIZU//MODEL STOMACH//BIOCHEM SETAGAYA KU |
32676 | 104 | ELSAMICIN A//CHARTREUSIN//ELSAMITRUCIN |
34485 | 70 | KRN5500//SPICAMYCIN//FUNCT PAIN NEUROIMAGING THER Y |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ARYNES | Author keyword | 91 | 60% | 2% | 98 |
2 | ENEDIYNES | Author keyword | 87 | 70% | 2% | 73 |
3 | ENEDIYNE | Author keyword | 75 | 65% | 2% | 71 |
4 | BERGMAN CYCLIZATION | Author keyword | 55 | 77% | 1% | 37 |
5 | ARYNE | Author keyword | 50 | 77% | 1% | 34 |
6 | C 1027 | Author keyword | 49 | 94% | 0% | 17 |
7 | LIDAMYCIN | Author keyword | 48 | 73% | 1% | 36 |
8 | NEOCARZINOSTATIN | Author keyword | 41 | 56% | 1% | 49 |
9 | NEOCARZINOSTATIN CHROMOPHORE | Author keyword | 30 | 100% | 0% | 12 |
10 | CYCLOAROMATIZATION | Author keyword | 28 | 69% | 1% | 24 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARYNES | 91 | 60% | 2% | 98 | Search ARYNES | Search ARYNES |
2 | ENEDIYNES | 87 | 70% | 2% | 73 | Search ENEDIYNES | Search ENEDIYNES |
3 | ENEDIYNE | 75 | 65% | 2% | 71 | Search ENEDIYNE | Search ENEDIYNE |
4 | BERGMAN CYCLIZATION | 55 | 77% | 1% | 37 | Search BERGMAN+CYCLIZATION | Search BERGMAN+CYCLIZATION |
5 | ARYNE | 50 | 77% | 1% | 34 | Search ARYNE | Search ARYNE |
6 | C 1027 | 49 | 94% | 0% | 17 | Search C+1027 | Search C+1027 |
7 | LIDAMYCIN | 48 | 73% | 1% | 36 | Search LIDAMYCIN | Search LIDAMYCIN |
8 | NEOCARZINOSTATIN | 41 | 56% | 1% | 49 | Search NEOCARZINOSTATIN | Search NEOCARZINOSTATIN |
9 | NEOCARZINOSTATIN CHROMOPHORE | 30 | 100% | 0% | 12 | Search NEOCARZINOSTATIN+CHROMOPHORE | Search NEOCARZINOSTATIN+CHROMOPHORE |
10 | CYCLOAROMATIZATION | 28 | 69% | 1% | 24 | Search CYCLOAROMATIZATION | Search CYCLOAROMATIZATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POTENT ANTITUMOR ANTIBIOTICS | 237 | 82% | 4% | 139 |
2 | CYCLOAROMATIZATION | 213 | 71% | 4% | 172 |
3 | NEOCARZINOSTATIN CHROMOPHORE | 204 | 65% | 5% | 196 |
4 | CALICHEMICIN GAMMA 1 | 166 | 86% | 2% | 85 |
5 | BERGMAN CYCLIZATION | 147 | 65% | 4% | 139 |
6 | ENEDIYNE | 137 | 75% | 2% | 98 |
7 | P BENZYNE | 135 | 74% | 3% | 101 |
8 | BENZYNE | 130 | 47% | 5% | 207 |
9 | ESPERAMICINS | 128 | 84% | 2% | 71 |
10 | DESIGNED ENEDIYNES | 105 | 88% | 1% | 50 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Recent advances in transition-metal-free carbon-carbon and carbon-heteroatom bond-forming reactions using arynes | 2012 | 127 | 103 | 92% |
Synthesis of indazole motifs and their medicinal importance: An overview | 2015 | 6 | 106 | 46% |
CHEMISTRY AND BIOLOGY OF THE ENEDIYNE ANTICANCER ANTIBIOTICS | 1991 | 918 | 132 | 95% |
One century of aryne chemistry | 2003 | 281 | 224 | 80% |
A Comprehensive History of Arynes in Natural Product Total Synthesis | 2012 | 170 | 151 | 42% |
The chemistry of enediynes, enyne allenes and related compounds | 1996 | 394 | 239 | 91% |
A Closer Look at Aryne Chemistry: Details that Remain Mysterious | 2013 | 42 | 58 | 90% |
Recent applications of aryne chemistry to organic synthesis. A review | 2008 | 123 | 173 | 75% |
Arynes and Cyclohexyne in Natural Product Synthesis | 2012 | 111 | 78 | 49% |
The use of arynes in organic synthesis | 2003 | 299 | 138 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOORGAN MED CHEM S | 10 | 43% | 0.5% | 18 |
2 | FUNCT PAIN NEUROIMAGING THER Y | 4 | 67% | 0.1% | 4 |
3 | SPENCER CHEM S 205 | 4 | 67% | 0.1% | 4 |
4 | FB 8 CHEM BIOL | 4 | 75% | 0.1% | 3 |
5 | FB CHEM BIOL 8 | 3 | 57% | 0.1% | 4 |
6 | EXCELLENCE CHEM METHODOL LIB DEV KU CMLD | 3 | 100% | 0.1% | 3 |
7 | KENNETH A SPENCER CHEM S 205 | 3 | 100% | 0.1% | 3 |
8 | COOPERAT DRUG DISCOVERY GRP | 3 | 21% | 0.3% | 13 |
9 | CENT 21142 NURUMIZU | 3 | 60% | 0.1% | 3 |
10 | NAT PROD LIB INITIAT | 2 | 22% | 0.2% | 7 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000018791 | MEYERS INTERDISCIPLINARY ORGAN MED CHE//BLEOMYCIN HYDROLASE//BLEOMYCIN AMPLIFICATION |
2 | 0.0000013667 | HALOGEN METAL PERMUTATION//HYDRANGEA MACROPHYLLA VAR THUNBERGII//ISOCOUMARIN |
3 | 0.0000010728 | AROMATICITY//CYCLOPHANES//CYCLACENES |
4 | 0.0000009764 | BISINDOLYL METHANES//CARBAZOLE ALKALOIDS//REBECCAMYCIN |
5 | 0.0000009256 | CROSS COUPLING//PALLADIUM//HECK REACTION |
6 | 0.0000008894 | DUOCARMYCINS//PYRROLOBENZODIAZEPINE//PYRROLE IMIDAZOLE POLYAMIDE |
7 | 0.0000008061 | SHIKONIN//BETA LAPACHONE//PLUMBAGIN |
8 | 0.0000007975 | HYDROAMINATION//ALKYNES//ALLENES |
9 | 0.0000006904 | NEWMAN WOLFROM CHEM//CHAIR PHYS ORGAN STRUCT CHEM//DIALKOXYCARBENE |
10 | 0.0000006222 | HYPERVALENT IODINE//BROMINATION//AROMATIC IODINATION |